Honeybear Biosciences
Honeybear Biosciences is headquartered in Taipei, Taiwan and has $20.0M in recorded funding across 1 round.
- Headquarters
- Taipei
- Business Model
- B2B
- Website
- honeybearbio.com
- Total Funding
- $20.0M
- Last Round
- $20.0M Series AJul 2026
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round for this company. The full record is or through the API.
About
Taiwan-based biotech developer creating antibody-drug conjugates for cancer patients using its proprietary Co-Nectar site-specific conjugation platform.
Summary
Honeybear Biosciences is a Biotech company based in Taipei, Taiwan. It has raised $20.0M in total across 1 round, most recently a $20.0M Series A round in Jul 2026.
Funding History
Jul 2026
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/honeybear-biosciences"><img src="https://indexed.vc/api/badge/company/honeybear-biosciences" alt="Honeybear Biosciences on Indexed.vc" width="260" height="76" /></a>